Volume 16 Number 12

This month a look at the ISCHEMIA trial in relation to real-world practice as applied to patients from the START registry; the novel DynamX bioadaptor system with uncaging elements allowing remodelling of the vessel wall; a post-hoc analysis of low wall shear stress and device target lesion failure from the ABSORB III imaging study; an MDCT study of impaired coronary access following redo TAVI; virtual reality use in conscious sedation during TAVI; coronary stent implantation in the treatment of intracranial stenoses; pulmonary arterial pressure as an indication for ASD closure; renal flow reserve and other haemodynamic measurements to inform revascularisation strategies for renal artery stenosis, and more...

In this issue of EuroIntervention

Applicability of the ISCHEMIA trial in real-world practice, a new “uncaging” coronary stent, PCI of the left main trifurcation in the EXCEL trial, coronary re-access after TAVI, virtual reality and conscious sedation, renal flow reserve, and more…

Capodanno D

free

Coronary interventions

External applicability of the ISCHEMIA trial: an analysis of a prospective, nationwide registry of patients with stable coronary artery disease

De Luca L, Uguccioni M, Meessen J, Temporelli P, Tomai F, De Rosa F, Passamonti E, Formigli D, Riccio C, Gabrielli D, Colivicchi F, Gulizia M, Perna G

10.4244/EIJ-D-20-00610

free

Editorial comment

Translating the findings of ISCHEMIA into clinical practice: a challenging START

Boden W, Bhatt D

10.4244/EIJV16I12A174

free

Twelve-month clinical and imaging outcomes of the uncaging coronary DynamX bioadaptor system

Verheye S, Vrolix M, Montorfano M, Zivelonghi C, Giannini F, Bedogni F, Dubois C, De Bruyne B, Costa R, Chamié D, de Ribamar Costa J, Kereiakes D, Abizaid A, Colombo A

10.4244/EIJ-D-20-00763

free

Editorial comment

"Uncaging" the artery with a novel metallic coronary device

Kimura T, Yamamoto K

10.4244/EIJV16I12A175

free

Procedural characteristics and clinical outcomes in patients undergoing percutaneous coronary intervention for left main trifurcation disease: the EXCEL trial

Kandzari D, Gershlick A, Serruys PW, Leon MB, Morice M, Simonton C, Lembo N, Mansour S, Sabaté M, Sabik J, Kappetein A, Dressler O, Stone GW

10.4244/EIJ-D-19-00686

free

Bioresorbable vascular scaffolds versus everolimus-eluting stents: a biomechanical analysis of the ABSORB III Imaging substudy

Kumar A, Gogas B, Thompson E, Burnett G, Molony D, Hosseini H, Chandran K, Lefieux A, Honda Y, Lee JM, Serruys PW, Kereiakes D, Stone GW, Samady H

10.4244/EIJ-D-19-01128

free

A randomised controlled trial of the sirolimus-eluting biodegradable polymer ultra-thin Supraflex stent versus the everolimus-eluting biodegradable polymer SYNERGY stent for three-vessel coronary artery disease: rationale and design of the Multivessel TALENT trial

Hara H, Gao C, Kogame N, Ono M, Kawashima H, Wang R, Morel M, O'Leary N, Sharif F, Möllmann H, Reiber JH, Sabaté M, Zaman A, Wijns W, Onuma Y, Serruys PW

10.4244/EIJ-D-20-00772

free

Interventions for valvular disease and heart failure

A computed tomography study of coronary access and coronary obstruction after redo transcatheter aortic valve implantation

Buzzatti N, Montorfano M, Romano V, De Backer O, Søndergaard L, Rosseel L, Maurovich-Horvat P, Karady J, Merkely B, Prendergast B, De Bonis M, Colombo A, Latib A

10.4244/EIJ-D-20-00475

free